Pricing Log in Create free account
Friday 6 November 2026 Export LQDA’s income statement to Excel — free account

Liquidia Corporation

LQDA Healthcare Drug Manufacturers Specialty & Generic

Liquidia Corporation’s revenue for fiscal 2025 (year ended December 2025) was $158.3 million, up 1,031.2% from fiscal 2024.

Revenue
+1,842.7%
EPS
+271.4%
Free cash flow
+270.2%
Total debt
−9.04%

Quarter to June 2026, against a year earlier

44.69 2.69 −5.68%
Market cap
$4.0B
P/E
28.5×
Fwd P/E
22.1×
Dividend yield
—
F-score
5/9
Altman Z
4.08
Beneish M
6.79
Dividend safety
n/a
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

Liquidia Corporation (LQDA) Current ratio

Alert me on Current ratio

Liquidia Corporation's current ratio at the end of the quarter to 30 June 2026 was 2.3×, up 0.3× from fiscal 2025 (2.0×). Over the past ten years it has ranged from 0.2× (fiscal 2017) to 11.3× (fiscal 2022); the current reading is higher than 25% of that period. That is in line with the Drug Manufacturers Specialty & Generic industry median of 2.4× and below the Healthcare sector median of 3.1×.

Current ratio, annual

Embed this chart

Annual newest first

Period Current ratio Change
FY2025 2.0× (54.55%)
FY2024 4.4× (8.58%)
FY2023 4.8× (57.27%)
FY2022 11.3× 0.00%
FY2022 11.3× 35.62%
FY2021 8.4× 0.00%
FY2021 8.4× 48.58%
FY2020 5.6× 0.00%
FY2020 5.6× 68.45%
FY2019 3.3× 0.00%

Quarterly newest first

Period Current ratio Change
Jun 2026 2.3× 3.96%
Mar 2026 2.2× 10.45%
Dec 2025 2.0× (8.57%)
Sep 2025 2.2× (11.71%)
29 more quarters

Against its own ten years

Low 0.2× High 11.3×
Ten-year median 4.8×
Current reading's percentile 25

Current ratio against peers

Company Current ratio
AMLX Amylyx Pharmaceuticals, Inc. compare 12.1×
RGC Regencell Bioscience Holdings Limited compare 10.8×
HCM HUTCHMED (China) Limited Sponsored ADR compare 5.6×
LNTH Lantheus Holdings, Inc. compare 3.2×
PBH Prestige Consumer Healthcare Inc. compare 2.9×
LQDA Liquidia Corporation 2.3×
AMRX AMNEAL PHARMACEUTICALS, INC. compare 1.9×
HIMS Hims & Hers Health, Inc. compare 0.9×
SUPN Indivior Pharmaceuticals Inc. compare 0.6×
Drug Manufacturers Specialty & Generic industry median 2.4×
Healthcare sector median 3.1×
Market median 1.6×

What Current ratio is

Current Ratio shows whether a company’s short-term assets are enough to cover the bills and debts it must pay within the next year.

Current Assets (Total) ÷ Current Liabilities (Total)

The full definition of Current ratio →

More on LQDA